Clinical application and importance of one-step human CYP2C19 genotype detection
- PMID:30360673
- PMCID: PMC6300956
- DOI: 10.1177/0300060518787718
Clinical application and importance of one-step human CYP2C19 genotype detection
Abstract
Background: To directly achieve cytochrome P450 2C19 gene ( CYP2C19) classification using one-step real-time fluorescent PCR detection and to verify the capabilities of this method with nucleic acid extracted from whole blood samples.
Methods: A human CYP2C19 genotyping kit based on one-step real-time fluorescent PCR detection was used to analyze whole blood or genomic DNA samples. This method was compared with pyrosequencing and another quantitative (q)PCR kit for its accuracy, repeatability, detection range analysis, sensitivity, specificity, and anti-interference analysis.
Results: The one-step real-time PCR method achieved a 100% accuracy rate compared with pyrosequencing and the other qPCR kit. When detecting different concentrations of known genes, concentrations of each sample ranging from 0.2 to 125 ng/µL could be correctly detected. The genotypes of samples treated with anticoagulants, including EDTA and sodium citrate, and chyle blood samples could be correctly detected.
Conclusion: The one-step detection method demonstrated high accuracy and a wide detection range. It also had high levels of repeatability, sensitivity, and specificity for the assessment of genomic DNA test samples.
Keywords: CYP2C19; Real-time fluorescent PCR; genotype detection; one-step detection.
Figures
Similar articles
- [The effects of cytochrome P450 2C19 genetic polymorphism on clopidogrel resistance and recent prognosis of patients with acute coronary syndrome].Li SN, Liu Z, Luo Y, Chen PA, Lei XM, Li GL.Li SN, et al.Zhonghua Nei Ke Za Zhi. 2013 Nov;52(11):961-5.Zhonghua Nei Ke Za Zhi. 2013.PMID:24439192Chinese.
- Comparison of the Microarray-Based Assay, the Real-Time PCR Assay, and the Bidirectional Sequencing Method for CYP2C19 Genotyping.Kim HK, Kang HJ, Ko DH, Jeong TD, Lee W, Chun S, Min WK.Kim HK, et al.Clin Lab. 2015;61(8):1109-12. doi: 10.7754/clin.lab.2015.141214.Clin Lab. 2015.PMID:26427158
- Comparison of Single Nucleotide Polymorphism genotyping of CYP2C19 by Loop-mediated isothermal amplification and real-time PCR melting curve analysis.Kwong KM, Tam CC, Chan R, Lee SWL, Ip P, Kwok J.Kwong KM, et al.Clin Chim Acta. 2018 Mar;478:45-50. doi: 10.1016/j.cca.2017.12.013. Epub 2017 Dec 13.Clin Chim Acta. 2018.PMID:29247634
- Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.Klein MD, Williams AK, Lee CR, Stouffer GA.Klein MD, et al.Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):647-652. doi: 10.1161/ATVBAHA.118.311963.Arterioscler Thromb Vasc Biol. 2019.PMID:30760018Review.
- Genetic Determinants of P2Y12 Inhibitors and Clinical Implications.Cavallari LH, Obeng AO.Cavallari LH, et al.Interv Cardiol Clin. 2017 Jan;6(1):141-149. doi: 10.1016/j.iccl.2016.08.010.Interv Cardiol Clin. 2017.PMID:27886818Free PMC article.Review.
Cited by
- Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe.Huebner T, Steffens M, Scholl C.Huebner T, et al.Mol Diagn Ther. 2022 Jan;26(1):89-103. doi: 10.1007/s40291-021-00567-x. Epub 2021 Dec 14.Mol Diagn Ther. 2022.PMID:34905151Free PMC article.Review.
References
- Jones S. Welcome to the 19th volume of Pharmacogenomics. Pharmacogenomics 2018; 19: 1–2. - PubMed
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous